According to researchers, lithium, a drug commonly used to treat bipolar disorder, and rapamycin can help to protect neurons from further damage in those with TBI.
Researchers discover a new mechanism of action for rapamycin that could help prevent neurological damage associated with neurodegenerative diseases.
According to a new study, an FDA approved drug prevented the development of Parkinson's disese in mice genetically engineered to develop the neurodegenerative disorder.
Rapamycin, a transplant anti-rejection drug, enhances survival and reduces the disease progression in a mouse model of Leigh's syndrome, a new study reports.
Researchers investigate how neurons are generated in hope to find potential new treatments for TSC and other neurological disorders.
Researchers have been able to identify and deactivate a brain pathway liked to memories associated with alcohol cravings in rats.
Researchers note reduced fear and stress responses following a mildly traumatic event when rapamycin, a protein synthesis blocker, is administered.
A new study discovers molecular pathways that could lead to new targeted therapies which may potentially treat Glioblastoma, the most common and lethal form of brain cancer in adults.
Researchers were able to regenerate an astonishing degree of axonal growth at the site of severe spinal cord injury in rats. Results were then replicated using two human stem cell lines, one already in human trials for ALS. “We obtained the exact results using human cells as we had in the rat cells,” said Tuszynski.
Hyperconnectivity triggered by loss of PTEN gene can be blocked by treatment with rapamycin. New research from Cold Spring Harbor...
